分支或开窗腔内修复治疗EVAR后1A型内漏的围术期与中期结局
本研究纳入2019至2024年一家大型教学医院连续24例因EVAR后1A型内漏接受分支或开窗腔内动脉瘤修复(B/FEVAR)的患者,评估动脉瘤相关死亡、总体生存、技术成功、内漏、瘤囊变化、再干预及靶血管通畅等结局。中位随访20个月,无动脉瘤相关死亡,总体生存96%,主要技术成功率88%,辅助主要技术成功率92%,2型内漏33%,3型内漏13%,瘤囊回缩17%、稳定71%、扩张13%,再干预25%,靶血管主要通畅率95%、辅助主要通畅率97%,靶血管不稳定8%。作者认为B/FEVAR似乎是处理既往EVAR后1A型内漏的安全有效选择。
要点
- 24例EVAR后1A型内漏患者接受B/FEVAR,中位随访20个月,无动脉瘤相关死亡,总体生存96%。
- 主要技术成功率88%,辅助主要技术成功率92%;2型内漏33%,3型内漏13%。
- 再干预率25%,靶血管主要通畅率95%、辅助主要通畅率97%,靶血管不稳定8%。
核心结论
- 基于中期结局,B/FEVAR似乎是处理既往EVAR后1A型内漏的安全有效选择。
研究设计与样本
- 单中心连续病例研究,纳入2019至2024年一家大型教学医院因EVAR后1A型内漏接受B/FEVAR的全部连续患者24例。
- B/FEVAR术后定期随访包括术后1、6、12个月及此后每年影像学检查。
主要发现
- 24例患者中男性占96%,中位年龄73岁(范围66-80),EVAR至B/FEVAR的中位间隔为6.6年(范围2-11)。
- 中位随访20个月(范围3-67),随访期间无动脉瘤相关死亡,总体生存率96%。
- 主要技术成功率为88%,辅助主要技术成功率为92%。
- 2型内漏发生率为33%,3型内漏发生率为13%。
- 随访期间瘤囊回缩占17%、稳定占71%、扩张占13%,25%的患者需要再干预。
关键数值与推荐
- 靶血管主要通畅率为95%,辅助主要靶血管通畅率为97%,靶血管不稳定为8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The treatment of a failing endovascular aneurysm repair (EVAR) due to loss of proximal sealing is challenging. Branched or fenestrated endovascular aneurysm repair (B/FEVAR) offers a promising endovascular solution. This study evaluates B/FEVAR outcomes for managing type 1A endoleak after EVAR. METHODS: All consecutive patients who underwent B/FEVAR surgery to treat a type 1A endoleak after EVAR at a large teaching hospital between 2019 and 2024 were included in this study. Outcomes analyzed included aneurysm-related mortality, overall survival, technical success, endoleaks, aneurysm sac dynamics, reinterventions, target vessel patency, target vessel instability, and other complications. Regular follow-up after B/FEVAR surgery included imaging at 1, 6, and 12 months, and annually thereafter. RESULTS: Among 24 patients (96% male, median age 73 (range: 66-80), the median interval between EVAR and B/FEVAR was 6.6 years (range: 2-11). No aneurysm-related mortality was observed during follow-up. The median follow-up was 20 months (range: 3-67), and overall survival was 96%. The primary technical success rate was 88%, and the assisted primary technical success rate was 92%. Type 2 endoleaks were observed in 33% of patients, while type 3 endoleaks occurred in 13% of patients. Aneurysm sac regression during follow-up was reported in 17%, stabilization in 71%, and expansion in 13% of patients. Reinterventions were required in 25% of patients. Primary target vessel patency and assisted primary target vessel patency were 95% and 97%. Target vessel instability was 8%. CONCLUSION: B/FEVAR appears to be a safe, and effective option for managing type 1A endoleaks after prior EVAR based on midterm outcomes.
引用
- Pierie SLR, Pierie MEN, Veeger NJGM, et al. Perioperative and Midterm Outcomes of Branched or Fenestrated Endovascular Aneurysm Repair for Type 1A Endoleak after Endovascular Aneurysm Repair. Ann Vasc Surg. 2025. PMID: 40414531. doi:10.1016/j.avsg.2025.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。